Prothrombin gene G20210A mutation in acute deep venous thrombosis patients with poor response to warfarin therapy

about

Progress in research into the genes associated with venous thromboembolism Epidemiology of Prothrombin G20210A Mutation in the Mediterranean Region.Factor V Leiden 1691G/A and prothrombin gene 20210G/A polymorphisms as prothrombotic markers in adult Egyptian acute leukemia patients.

P2860

Q28084640-5F46D050-3598-48AD-B4D3-E972250DDC24 Q35640739-65BC75B8-7933-44FF-9DF3-CE056A09FA1C Q38985825-9650DEDC-85FF-412C-8A8A-DFE4A55C1A81

P2860

Prothrombin gene G20210A mutation in acute deep venous thrombosis patients with poor response to warfarin therapy

Item

http://www.wikidata.org/entity/Q42640925

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Prothrombin gene G20210A mutat ...... r response to warfarin therapy

@en

Prothrombin gene G20210A mutat ...... r response to warfarin therapy

@nl

type

Item

label

Prothrombin gene G20210A mutat ...... r response to warfarin therapy

@en

Prothrombin gene G20210A mutat ...... r response to warfarin therapy

@nl

prefLabel

Prothrombin gene G20210A mutat ...... r response to warfarin therapy

@en

Prothrombin gene G20210A mutat ...... r response to warfarin therapy

@nl

P1476

Prothrombin gene G20210A mutat ...... r response to warfarin therapy

@en

P2093

D P Mikhailidis

http://www.w3.org/2001/XMLSchema#string

F M Attia

http://www.w3.org/2001/XMLSchema#string

S A Reffat

http://www.w3.org/2001/XMLSchema#string

P2860

The genetic basis of resistance to anticoagulants in rodents

Nucleotide sequence of the gene for human prothrombin

An allosteric switch controls the procoagulant and anticoagulant activities of thrombin

Human genes encoding prothrombin and ceruloplasmin map to 11p11-q12 and 3q21-24, respectively.

Cardiology patient pages. Prothrombin 20210 mutation (factor II mutation).

A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.

ABC of antithrombotic therapy: Antithrombotic therapy in special circumstances. II-In children, thrombophilia, and miscellaneous conditions

Inherited predisposition to thrombosis.

Case studies in therapeutics: warfarin resistance and inefficacy in a man with recurrent thromboembolism, and anticoagulant-associated priapism.

CYP2C9 and VKORC1 genetic polymorphism analysis might be necessary in patients with Factor V Leiden and prothrombin gene G2021A mutation(s).

P304

147-151

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1874192400903010147

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38096650

http://www.w3.org/2001/XMLSchema#string

P698

19920886

http://www.w3.org/2001/XMLSchema#string

P921

thrombosis

P932

2778014

http://www.w3.org/2001/XMLSchema#string

Prothrombin gene G20210A mutation in acute deep venous thrombosis patients with poor response to warfarin therapy

about

P2860

P2860

Prothrombin gene G20210A mutation in acute deep venous thrombosis patients with poor response to warfarin therapy

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P921

P932